Healthcare - Drug Manufacturers - General - NYSE - US
$ 15.03
-1.83 %
$ 3.87 B
Market Cap
3.04
P/E
BALANCE SHEET
12.1 B
ASSETS
12.1 B
LIABILITIES
-70 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Organon & Co.
| Current Assets | 4.51 B |
| Cash & Short-Term Investments | 693 M |
| Receivables | 1.74 B |
| Other Current Assets | 2.07 B |
| Non-Current Assets | 7.55 B |
| Long-Term Investments | 0 |
| PP&E | 1.18 B |
| Other Non-Current Assets | 6.37 B |
| Current Liabilities | 2.92 B |
| Accounts Payable | 1.31 B |
| Short-Term Debt | 9 M |
| Other Current Liabilities | 1.6 B |
| Non-Current Liabilities | 9.21 B |
| Long-Term Debt | 8.88 B |
| Other Non-Current Liabilities | 334 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | ||
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Cash & Cash Equivalents | 693.0 | 706.0 | 737.0 | 500.0 | 319.0 | 244.0 | |
| Short Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | |
| Receivables | 1 744.0 | 1 475.0 | 1 382.0 | 1 090.0 | 1 560.0 | 1 593.0 | |
| Inventory | 1 315.0 | 1 003.0 | 915.0 | 913.0 | 1 071.0 | 994.0 | |
| Other Current Assets | 756.0 | 747.0 | 726.0 | 1 552.0 | 1 005.0 | 883.0 | |
| Total Current Assets | 4 508.0 | 3 931.0 | 3 760.0 | 3 434.0 | 3 955.0 | 3 714.0 | |
| PP&E | 1 183.0 | 1 018.0 | 973.0 | 984.0 | 680.0 | 651.0 | |
| Intangible Assets | 533.0 | 649.0 | 651.0 | 503.0 | 569.0 | 812.0 | |
| Goodwill | 4 603.0 | 4 603.0 | 4 603.0 | 4 603.0 | 4 603.0 | 4 603.0 | |
| Long Term Investments | 0 | 0 | (4.0) | 0 | 0 | 0 | |
| Other Long Term Assets | 1 184.0 | 735.0 | 694.0 | 910.0 | 741.0 | 714.0 | |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 | |
| Total Assets | 12 058.0 | 10 955.0 | 10 681.0 | 10 434.0 | 10 548.0 | 10 494.0 | |
| LIABILITIES | |||||||
| Accounts Payable | 1 314.0 | 1 132.0 | 1 382.0 | 259.0 | 258.0 | 289.0 | |
| Short Term Debt | 9.0 | 8.0 | 9.0 | 16.0 | 34.0 | (207.0) | |
| Other Current Liabilities | 1 389.0 | 1 188.0 | 1 021.0 | 2 289.0 | 807.0 | 497.0 | |
| Total Current Liabilities | 2 918.0 | 2 512.0 | 2 597.0 | 1 201.0 | 1 341.0 | 1 545.0 | |
| Long Term Debt | 8 876.0 | 9 055.0 | 9 309.0 | 46.0 | 70.0 | 34.0 | |
| Deferred Tax Income | 47.0 | 19.0 | 4.0 | 121.0 | 139.0 | 149.0 | |
| Other Liabilities | 287.0 | 261.0 | 279.0 | 1 904.0 | 1 963.0 | 2 567.0 | |
| Total Liabilities | 12 128.0 | 11 847.0 | 12 189.0 | 11 254.0 | 3 513.0 | 4 146.0 | |
| EQUITY | |||||||
| Common Stock | 3.0 | 3.0 | 3.0 | 3.0 | 7 949.0 | 7 256.0 | |
| Retained Earnings | 443.0 | (331.0) | (998.0) | (219.0) | 0 | 0 | |
| Other Accumulative Comprehensive Income/Loss | (541.0) | (564.0) | (513.0) | (604.0) | (914.0) | (908.0) | |
| Total Equity | (70.0) | (892.0) | (1 508.0) | (820.0) | 7 035.0 | 6 348.0 | |
| Total Liabilities and Equity | 12 058.0 | 10 955.0 | 10 681.0 | 10 434.0 | 10 548.0 | 10 494.0 | |
| SHARES OUTSTANDING | |||||||
| Common Shares Outstanding | 255.2 | 254.1 | 253.6 | 253.5 | 253.1 | 253.1 | 253.1 |